The finding that both KI67 and p53 are over-expressed in a relevant fraction of our patients exhibiting poor outcome is in agreement with numerous published studies attributing to the above proteins a role as predictors of adverse prognosis in several human tumour types, including head and neck cancers. Here, TP53 is linked to neoplasm.